Improving outcomes with radical cystectomy for high-grade invasive bladder cancer

World Journal of Urology

Volumn 24, Issue 5, 2006, Pages 509-516

  Stein, John P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Hospital volume; Lymph node metastases; Lymphadenectomy; Surgical delay; Surgical volume; Transitional cell carcinoma

Indexed keywords

ARTICLE; BLADDER TUMOR; CANCER INVASION; CYSTECTOMY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METHODOLOGY; PATHOLOGY; TREATMENT OUTCOME;

CYSTECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 33751213892     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-006-0111-1     Document Type: Article

References (41)

1. Jamal A, Taylor M, Ward E et al (2005) Cancer statistics 2005. CA Cancer J Clin 55:10-20
2. Prout G, Marshall VF (1956) The prognosis with untreated bladder tumors. Cancer 9:551-558
3. Sanchez-Ortiz RF, Huang W, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB (2003) An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169:110-115
4. Lee CT, Madii R, Daignault S, Dunn RL, Zhang Y, Montie JE, Wood DP Jr. (2006) Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175:1262-1267
5. Hautmann RE, Paiss T (1998) Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy? J Urol 159:1845-1850
6. Chang SS, Hassan M, Cookson MS, Wells N, Smith JA Jr (2003) Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170:1085-1087
7. Muhmud SM, Fong B, Fahmy N, Tanguay S, Aprikian AG (2006) Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: A population based study. J Urol 175:78-83
8. Liedberg F, Anderson H, Mansson W (2005) Treatment delay and prognosis in invasive bladder cancer. J Urol 174:1777-1781
9. Wiesner C, pfitzenmaier J, Faldum A, Gillitzer R, Melchior SW, Thuroff JW (2005) Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU Int 95:301-305
10. May M, Nitzke T, Helke C, Vogler H, Hoschke B (2004) Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Scand J Urol Nephrol 38:231-235
11. Herr HW (2005) Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin North Am 32:157-164
12. Lange PH, Lin DW (2004) Does the who and how of surgery in bladder cancer matter. J Clin Oncol 22:2762
13. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng A-C, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19:666-675
14. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128-1137
15. Birkmeyer JD, Sun Y, Goldfaden A, Birkmeyer NJO, Stukel TA (2006) Volume and process of care in high-risk cancer surgery. Cancer 106:2476-2481
16. Begg CB, Reidel ER, Bach PB et al (2002) Variations in morbidity after radical prostatectomy. N Engl J Med 346:1138-1144
17. Dimick J, Pronovost P, Cowan JA, Lipsett P, Stanley J, Upchurch GJ (2003) Variation in postoperative complication rates after high-risk surgery in the United States. Surgery 134:534-540
18. Elting LS, Pettaway C, Bekele BN, Grossman BH, Cooksley C, Avritscher EBC, Dinney CP (2005) Correlation between annual volume of cystectomy, professional staffing and outcomes. Cancer 104:975-984
19. Konty BR, Allareddy V, Modak S, Smith B (2006) Mortality after major surgery for urologic cancers in specialized urologic hospital: Are they any better? J Clin Oncol 24:2006-2012
20. Birkmeyer J, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349:2117-2127
21. Herr H, Lee C, Chang S, Lerner S (2004a) For the Bladder Cancer Collaborative Group: Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer; a collaborative group report. J Urol 171:1823-1828
22. McCabe JE, Jibawi A, Javle P (2005) Defining the minimum hospital case-load to achieve optimum outcomes in radical cystectomy. BJU Int 96:806-810
23. National Institute of Clinical Excellence(2003) Draft, Urologic Cancer Standards: Manual of cancer services standards. National Institute of Clinical Excellence, London
24. Herr HW, Faulkner JR, Grossman HB, Natale RB, White RD, Sarosdy MF, Crawford ED (2004) Surgical factors influence bladder cancer outcomes: A cooperative group report. J Clin Oncol 22:2781-2789
25. Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL et al (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859-866
26. Barth PJ, Gerharz EW, Ramaswamy A et al (1999) The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. Pathol Res Pract 195:633-636
27. Terrone C, Guercio S, DeLuca S, Poggio M, Castelli E, Scoffone C, Tarabuzzi R, Scarpa RM, Fontana D, Rossetti SR (2003) The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 91:37-40
28. Stein JP, Quek ML, Skinner DG (2006) Lymphadenectomy for invasive bladder cancer: I. Historical perspective and contemporary rationale. BJU Int 97:227-231
29. Stein JP, Quek ML, Skinner DG (2006) Lymphadenectomy for invasive bladder cancer. II. Technical aspects and prognostic factors. BJU Int 97:232-237
30. Stein JP (2003) Indications for early cystectomy. Urology 62:591-595
31. Leissner J, Ghoneim MA, Abol-Enein H, Thuroff JW, Franzaring L, Fisch M, Schulze H et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: Results of a prospective multicenter study. J Urol 171:139-144
32. Poulsen AL, Horn T, Steven K (1998) Radical cystectomy; extending limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160:2015-2020
33. Vieweg J, Gschwend JE, Herr HW, Fair WR (1999) The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 161:72-76
34. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85:817-823
35. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP (2004) Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 171:1830-1834
36. Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA (2004) Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 172:85-89
37. Smith JA, Whitmore WF Jr (1981) Regional lymph node metastasis from bladder cancer. J Urol 126:591-593
38. Bochner BH, Cho C, Herr HW, Donat M, Kattan MW, Dalbagni G (2004) Prospective packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 172:1286-1290
39. Brossner C, Pycha A, Toth A, Mian C, Kuber W (2004) Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 93:64-66
40. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295-1298
41. Konety BR, Joslyn SA, O'Donnell MA (2003) Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the surveillance, epidemiology and end results program data base. J Urol 169:945-950